Position in VRTX
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$135,389,224
+$46,339,772 QoQ
Shares Held
272,561
+36.7% QoQ
Ownership
0.108%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#92
of 1,742 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 58%
Shared 0%
None 42%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BAILLIE GIFFORD & CO holds $3,256,235,173 across 13 Biotechnology names. VRTX ranks #5 (4.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
18,206,778 | $1,275,020,662 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,439,889 | $734,479,783 | |
| 3 | RPRX |
Royalty Pharma plc
|
10,015,578 | $561,573,456 | |
| 4 | DNLI |
Denali Therapeutics Inc.
|
11,960,230 | $307,617,113 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
272,561 | $135,389,224 | |
| 6 | RXRX |
Recursion Pharmaceuticals, Inc.
|
23,487,907 | $86,200,617 | |
| 7 | BNTX |
BioNTech SE
|
592,380 | $55,120,957 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
263,466 | $49,341,910 |
All Filings in VRTX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $135,389,224 | 272,561 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $89,049,452 | 199,421 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $91,165,254 | 201,088 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $81,091,411 | 207,056 | Shares | Defined | 2025-10-31 | |
| 2025-06-30 | $94,595,649 | 212,479 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $65,191,320 | 134,465 | Shares | Defined | 2025-05-07 | |
| 2024-12-31 | $60,339,760 | 149,838 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $65,380,944 | 140,580 | Shares | Defined | 2024-11-05 | |
| 2024-06-30 | $78,564,970 | 167,616 | Shares | Defined | 2024-07-25 | |
| No filing history on record for this holder in this stock. | ||||||